Snodgrass D R
Vet Rec. 1986 Jul 12;119(2):39-42. doi: 10.1136/vr.119.2.39.
A vaccine of rotavirus and K99 antigen from enterotoxigenic Escherichia coli was emulsified in oil adjuvant and administered intramuscularly to pregnant cows. Calves born to and reared on vaccinated dams were protected against experimental rotavirus infection at five days old when compared with calves from unvaccinated control cows. Field trials of the vaccine were carried out in 40 commercial herds, in which half the cows in each herd were selected at random for vaccination and half were left unvaccinated. In 31 herds (2641 cows) there was no significant diarrhoea problem (less than 10 per cent morbidity); these herds were excluded from further analysis. The nine remaining herds did experience a calf diarrhoea problem of greater than 10 per cent morbidity, but on four farms the disease was associated with cryptosporidiosis and on a fifth no enteropathogens were detected; these five farms (461 cows) were also excluded from further analysis. Of the remaining four herds, two beef suckler herds (105 cows) had concurrent rotavirus and cryptosporidial infections, and vaccination was associated with a decreased excretion of rotavirus but not with a decreased incidence of diarrhoea. In the other two dairy herds (68 cows) with prevaccination rotavirus problems, there was a significantly decreased incidence of diarrhoea in calves born to vaccinated cows. No natural field challenge of enterotoxigenic E coli was encountered on any of the trial farms.
将轮状病毒疫苗和产肠毒素大肠杆菌的K99抗原乳化于油佐剂中,对怀孕母牛进行肌肉注射。与未接种疫苗的对照母牛所生的犊牛相比,接种疫苗的母牛所生并由其饲养的犊牛在5日龄时能抵御实验性轮状病毒感染。该疫苗在40个商业牛群中进行了田间试验,每个牛群中随机选择一半母牛进行接种,另一半不接种。在31个牛群(2641头母牛)中没有明显的腹泻问题(发病率低于10%);这些牛群被排除在进一步分析之外。其余9个牛群确实经历了发病率超过10%的犊牛腹泻问题,但在4个农场,该疾病与隐孢子虫病有关,在第5个农场未检测到肠道病原体;这5个农场(461头母牛)也被排除在进一步分析之外。在其余4个牛群中,2个肉用哺乳牛群(105头母牛)同时感染了轮状病毒和隐孢子虫,接种疫苗与轮状病毒排泄减少有关,但与腹泻发病率降低无关。在另外2个接种疫苗前存在轮状病毒问题的奶牛群(68头母牛)中,接种疫苗的母牛所生犊牛的腹泻发病率显著降低。在任何试验农场都未遇到产肠毒素大肠杆菌的自然田间挑战。